CRP and diffuse large B-cell lymphoma: We found 19 prognostic studies that either assessed CRP only [38–40], PA only [41–49], or both [14–20] in patients with DLBCL, most of which amended CRP and/or PA to globally accepted prognostic DLBCL indices [14–20,38–42,44,46,48,49].